ArticleHuman cell2025
Partial TEX14 peptides inhibit proliferation of cancer cells and have potential as anti-tumour agents.
Article in Human cell, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
TEX14 is essential for the formation and maintenance of the intercellular bridge (ICB) which is one of the major cellular junctions required for spermatogenesis. Previously, TEX14 was shown to block germ cell abscission prior to cytokinesis through the GPPX3Y (Gly-Pro-Pro-X-X-X-Tyr) motif. Although TEX14 could have the potential to inhibit cell proliferation, it is difficult for full-length TEX14 to be applied as anti-tumour agents because of its molecular size. In addition, the involvement of amino acids surrounding the GPPX3Y motif in the ICB formation as well as cell proliferation remains to be investigated for anti-tumour treatment. In this study, we show that partial peptides of TEX14, which include the GPPX3Y motif, are sufficient to inhibit the proliferation of a variety of cancer cells and efficiently induce apoptosis. In addition, the length and variation of amino acids surrounding the GPPX3Y motif might attenuate the efficiency of partial TEX14 peptides to inhibit cell proliferation as well as to induce apoptosis. Thus, our findings suggest that these TEX14 short peptides could be useful to suppress cell division in continuously proliferating cells such as cancer cells without affecting germ cell differentiation and have the potential as anti-tumour agents.
Indexed as
Identifiers
41219627What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.